P
Perrigo
Quality, affordable self-care products trusted by consumers globally
About Perrigo
Perrigo Company plc is a leading global provider of high-quality, affordable self-care products. Operating in the consumer healthcare market, Perrigo serves a diverse range of clients including retail chains, pharmacies, and direct consumers. The company’s business model focuses on manufacturing and distributing over-the-counter (OTC) healthcare products, infant formulas, and nutritional products. Perrigo generates revenue through the sale of these products under both its own brand and private labels for retailers. The company leverages its extensive manufacturing capabilities and commitment to quality to maintain competitive pricing while ensuring product efficacy and safety. Additionally, Perrigo is dedicated to community well-being through its charitable foundation, which supports educational programs, healthcare access, and disaster relief efforts.
Source: Dealroom company dataAt a glance
- Status
- Listed
- Founded
- 1887
- Headquarters
- Dublin, Ireland
- Listing
- IPO 1991
- Employees
- 6,009
- Open positions
- 56
- Dealroom signal
- 66.7/100
- Industry
- Health
- Sub-industry
- Health Platform
- Sector
- Health Tech & Medtech, Biotechnology
- Business model
- Manufacturing
- Client focus
- b2b
- Investment activity
- 9 companies, latest Sep 2021
- Capital deployed
- —
- Preferred round
- ACQUISITION
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| POST IPO DEBT✓Debt | Sep 2024 | $0 | — | Undisclosed | ↗ |
| POST IPO EQUITY✓Other financing | Sep 2016 | $600M | — | Starboard Value | — |
Financials
Revenue, earnings and other financial measures where available. Years marked “E” are estimates.
Growth signals
Latest recorded traffic for Perrigo is 75K monthly website visits, up 200% over the last three months. Perrigo's team grew 0.1% over the past year.
Open positions
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
HRA PharmaChâtillon, FranceHRA Pharma- Pioneering treatments in women's health and endocrinology
$2Bvaluation
RanirGrand Rapids, United StatesLeading global manufacturer of private label consumer oral and personal care products
$750Mvaluation
GD
Geiss, Destin & DunnPeachtree City, United StatesSmall national distributor of over-the-counter healthcare and consumer goods products
→
ScarAwayUnited StatesAn OTC scar management brand
→
Omega Pharma NVNazareth-De Pinte, BelgiumEngages in the development and sale of prescription-free health and personal care products to pharmacies
$4.5Bvaluation
Fera PharmaceuticalsUnited States
→
Rosemont PharmaceuticalsLeeds, United KingdomRosemont Pharmaceuticals manufactures and supplies liquid medicines
$242Mvaluation
VelceraYardley, United StatesAffordable, vet-quality pet care products for comprehensive health solutions
→
Elan CorporationDublin, Ireland
$8.6Bvaluation
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series B and later1 investor entered at this stage
Starboard Value
Other known investors1 additional known investor
HAO Capital
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about Perrigo on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Perrigo’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.